GÜNDÜZ, E. 2017. Can a patient with CML and MR4 or MR5 can stop treatment?. 4th Aegean Hematology and Oncology Symposium .

GÜNDÜZ, E., (2017). Can a patient with CML and MR4 or MR5 can stop treatment? . 4th Aegean Hematology and Oncology Symposium

GÜNDÜZ, EREN. "Can a patient with CML and MR4 or MR5 can stop treatment?," 4th Aegean Hematology and Oncology Symposium, 2017

GÜNDÜZ, EREN. "Can a patient with CML and MR4 or MR5 can stop treatment?." 4th Aegean Hematology and Oncology Symposium , 2017

GÜNDÜZ, E. (2017) . "Can a patient with CML and MR4 or MR5 can stop treatment?." 4th Aegean Hematology and Oncology Symposium .

@conferencepaper{conferencepaper, author={EREN GÜNDÜZ}, title={Can a patient with CML and MR4 or MR5 can stop treatment?}, congress name={4th Aegean Hematology and Oncology Symposium}, city={}, country={}, year={2017}}